"Ovarian cancer survival" trang 1 - tải miễn phí từ tailieunhanh
Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
8    74    1
Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: A metaanalysis of overall survival and disease-free survival

Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: A metaanalysis of overall survival and disease-free survival
11    89    0
Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer

Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer
9    53    0
Long-term mortality among women with epithelial ovarian cancer: A populationbased study in British Columbia, Canada

Long-term mortality among women with epithelial ovarian cancer: A populationbased study in British Columbia, Canada
9    50    1
Impact of diabetes mellitus on epithelial ovarian cancer survival

Impact of diabetes mellitus on epithelial ovarian cancer survival
6    37    1
Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
11    22    1
Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer

Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer
9    51    1
HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways

HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways
20    8    1
Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer

Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer
13    49    1
Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: A case comparison study

Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: A case comparison study
9    38    1
Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study

Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study
13    29    1
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: A retrospective cohort study

Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: A retrospective cohort study
9    101    0
A multi-center population-based case-control study of ovarian cancer in African-American women: The African American Cancer Epidemiology Study (AACES)

A multi-center population-based case-control study of ovarian cancer in African-American women: The African American Cancer Epidemiology Study (AACES)
13    46    1
Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer propensity score- matched analysis

Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer propensity score- matched analysis
7    77    0
Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
12    1    1
Prior oral contraceptive use in ovarian cancer patients: Assessing associations with overall and progression-free survival

Prior oral contraceptive use in ovarian cancer patients: Assessing associations with overall and progression-free survival
7    75    1
Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients

Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
8    23    1
Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival

Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival
11    28    1
The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors

The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors
11    60    1
Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients
9    55    1